FDA Inspection 1250496 — Michael J. DiGiovanna, D.O., C.P.I.

Michael J. DiGiovanna, D.O., C.P.I. — FEI 3006401441

The FDA completed an inspection of Michael J. DiGiovanna, D.O., C.P.I. on Sep 5, 2024 in North Massapequa, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Sep 5, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
North Massapequa, NY (United States)

Additional Details

Clinical Investigator (CI)